CG
BIIB icon

Carmignac Gestion’s Biogen BIIB Stock Holding History

Carmignac Gestion’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-361,395
Closed -$93.5M – 146
2023
Q4 		$93.5M Buy
361,395
+52,295
+17% +$12.8M 1.57% 21
2023
Q3 		$79.4M Sell
309,100
-1,000
-0.3% -$267K 1.46% 21
2023
Q2 		$88.3M Hold
310,100
– – 1.52% 22
2023
Q1 		$86.2M Buy
+310,100
New +$85.8M 1.44% 26

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carmignac Gestion's BIIB Position: Q1 2024 in Review

Carmignac Gestion sold out of Biogen (BIIB) in Q1 2024, closing a stake of 361,395 shares — an estimated $93.5M sold.

Carmignac Gestion first reported a position in BIIB in Q1 2023 and held it in 4 quarters. The position peaked at $93.5M in Q4 2023. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Carmignac Gestion reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Carmignac Gestion sold 361,395 Biogen shares in Q1 2024, an estimated $93.5M.
  • Carmignac Gestion first reported a position in Biogen in Q1 2023 and held it in 4 quarters.
  • Carmignac Gestion's Biogen position peaked at $93.5M in Q4 2023.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.